作者: Hedy L. Kindler , Sandra Nolte , Colin Johnson , Seongjung Joo , Nikunj Patel
DOI: 10.1200/JCO.2021.39.3_SUPPL.393
关键词:
摘要: 393Background: Metastatic pancreatic cancer (mPC) and its treatments significantly impact patients’ (pts) health-related quality of life (HRQoL). POLO, a randomized, double-blind, placebo-controlle...